Analysis of the Global Fibrinogen Market and Product Pipeline

Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth

USD 6,000

* Required Fields

USD 6,000

PAY BY INVOICE

Be the first to review this product

The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed and pipeline products are segmented based on their therapeutic uses, namely, deficiency therapy and operative care. An elaborate discussion on clinical trial timelines and results, along with historical and projected launch timelines, has been provided. The study also discusses key companies such as CSL Behring, LFB, Baxter Healthcare, Takeda, Grifols, and Octapharma.

Table of Contents

Executive SummaryExecutive Summary—Key FindingsExecutive Summary—Key Findings (continued)Key TrendsCompanies to WatchMethodology and ScopeMethodology and ScopeMarket BackgroundMarket Overview—IntroductionMarket Overview—Blood Plasma ProductionMarket SegmentationBlood Plasma Market ShareFibrinogen ProductionRevenue ForecastRevenue Forecast DiscussionSupply Chain and Distribution NetworkSupply Chain and Distribution Network (continued)Competitive Landscape—Human Fibrinogen (Marketed and Pipeline Products)Competitive Landscape—Marketed and Pipeline ProductsCompetitive Landscape OverviewMarketed Products—Deficiency and Other TherapiesPipeline Products—Deficiency and Other TherapiesMarketed Products—Operative CareMarketed Products—Operative Care (continued)Pipeline Products—Operative CarePivotal Phase 3 TrialsFibrinogen Market—Major On-going/Recently Completed Clinical TrialsFibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)Summary of Key Products to WatchSummary of Key Products to Watch (continued)Timeline of Key Events—Launch of ProductsProduct Dashboard (Key Marketed and Phase 3 Products)Product Dashboard—Haemocomplettan/RiaSTAP (CSL Behring)Product Dashboard—Clottafact (LFB)Product Dashboard—Octafibrin (Octapharma)Product Dashboard—Artiss (Baxter Healthcare)Product Dashboard—Evarrest (Ethicon)Product Dashboard—Raplixa (The Medicines Company)Product Dashboard—FS Grifols (Grifols)ConclusionsConclusionsLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation Excellence




Related Research

Release Date : 13-Oct-17

Region : Global

Release Date : 13-Oct-17

Region : Global

Release Date : 11-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.